-
1.
公开(公告)号:EP3803391A1
公开(公告)日:2021-04-14
申请号:EP19726722.2
申请日:2019-05-31
申请人: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM , Centre national de la recherche scientifique , UNIVERSITE D'ANGERS , Universite de Nantes , ASSISTANCE PUBLIQUE, HOPITAUX DE PARIS , Sorbonne Université
-
2.PEPTIDES DERIVES DE LA PROTEINE MMP-2 ET LEUR UTILISATION EN IMMUNOTHERAPIE ANTITUMORALE 审中-公开
标题翻译: MMP-2的肽片段及其用途癌症免疫公开(公告)号:EP1635862A1
公开(公告)日:2006-03-22
申请号:EP04767441.1
申请日:2004-06-24
IPC分类号: A61K38/48 , C07K4/12 , A61K39/00 , A61K38/08 , A61K48/00 , C12N15/11 , C12N5/10 , G01N33/68 , A61P35/00
CPC分类号: C12N9/6491 , A61K2035/124 , A61K2039/5154 , A61K2039/5156 , A61K2039/5158 , A61K2039/5256 , A61K2039/53 , A61K2039/57 , C12N5/0636
摘要: The invention relates to peptides forming epitopes T of the antigen MMP-2, presented by MHC class I. Said peptides can especially be used in antitumoral immunotherapy.
-